FOLLOW US

  • facebook
  • twitter
Thu

March 12, 2026

GSK completes acquisition of IDRx

America February 24, 2025

GSK Completes Acquisition of IDRx

Pharmaceutical giant GSK has officially sealed its acquisition of biopharma company IDRx Inc. in a high-stakes $1.15 billion deal aimed…

By Rihem Akkouche

America October 4, 2024

Haleon Boosts China Presence with Advil $637M Investment in Joint Venture

British consumer healthcare giant Haleon plc announced on Friday that it will invest roughly $637 million to significantly increase its…

By USA Herald

GSK To Put Up To $7.2B Into Biotech VCs Pipeline

America July 30, 2024

GSK To Put Up To $7.2B Into Biotech VC’s Pipeline

GlaxoSmithKline announced Monday it will invest up to $7.2 billion in a biotech venture capital firm’s research and development pipeline,…

By Rihem Akkouche

America June 5, 2024

Zantac Cancer Suits Should Stay in Connecticut, Plaintiffs Argue

Lawsuits claiming Zantac and its generic equivalents caused cancer belong in Connecticut state court, two groups of Constitution State cancer…

By Rochdi Rais

Delaware judge lets more than 70,000 Zantac lawsuits go forward

America June 2, 2024

Delaware judge lets more than 70,000 Zantac lawsuits go forward

A Delaware judge has allowed more than 70,000 lawsuits regarding the discontinued heartburn drug Zantac to move forward. This decision,…

By Rihem Akkouche

GSK Sells £978M Worth Of Shares in Haleon PLC

America January 17, 2024

GSK Sells £978M Worth Of Shares in Haleon PLC

In a strategic financial move, pharmaceutical powerhouse GSK (formerly GlaxoSmithKline) announced on Wednesday that it has successfully divested a significant…

By Rihem Akkouche

GSK To Buy Drug Biz For $1.4B

America January 9, 2024

GSK To Buy Drug Biz For $1.4B: Deal to Acquire Aiolos Bio Inc. Unveiled

In a bold move to bolster its respiratory treatments arsenal, GSK PLC, the British pharmaceutical giant, announced a groundbreaking deal…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter